0001562180-16-001386.txt : 20160122
0001562180-16-001386.hdr.sgml : 20160122
20160122162512
ACCESSION NUMBER: 0001562180-16-001386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160120
FILED AS OF DATE: 20160122
DATE AS OF CHANGE: 20160122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufman Richard E
CENTRAL INDEX KEY: 0001614649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 161356488
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
STREET 2: C/O INTERSECT ENT, INC.
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-01-20
false
0001271214
Intersect ENT, Inc.
XENT
0001614649
Kaufman Richard E
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
Sr VP& Chief Operating Officer
Common Stock
2016-01-20
4
S
false
3603.00
17.9876
D
212586.00
D
Common Stock
2016-01-21
4
S
false
3603.00
17.8719
D
208983.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.94 to $18.02, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.74 to $18.20, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
/s/ Jeryl L. Hilleman, Attorney-in-Fact for Richard E. Kaufman
2016-01-21